Key result
Resin hemoperfusion drastically reduced serum digoxin levels and reverted symptoms in a case of severe suicidal digoxin toxicity.
Why the study?
Does resin hemoperfusion reduce serum digoxin levels and improve symptoms in severe digoxin toxicity?
Case Report (n=1)
Does resin hemoperfusion reduce serum digoxin levels and improve symptoms in severe digoxin toxicity?
Resin hemoperfusion may be an effective alternative treatment for severe digoxin toxicity in settings where digoxin-specific antibody fragments are unavailable.
May support resin hemoperfusion when Fab unavailable; leaves open need for controlled trials.
Owing to its wide and easy availability, digoxin has got a significant abuse potential and may be used for suicidal purposes. Digoxin-specific antibody (Fab) fragments have become the mainstay of therapy for severe digoxin toxicity and have significantly helped in reducing mortality. However, due to its high cost and limited availability alternative measures may need to be used to manage severe intoxications especially in countries like India, where Fab fragments are unavailable. Here, we present a case of a young female who presented to our casualty with alleged history of consumption of 17.5 mg of digoxin tablets. After admission to ICU, she developed atrioventricular blocks with hemodynamic instability which had to be managed with temporary pacemaker. Her serum digoxin levels were high (12.63 ng/ml) and in the absence of Fab fragments, resin hemoperfusion was done which drastically reduced the serum digoxin levels and reverted the symptoms.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2012) conducted a case report in Severe suicidal digoxin toxicity (n=1). Resin hemoperfusion was evaluated on Serum digoxin levels and symptoms. Resin hemoperfusion drastically reduced serum digoxin levels and reverted symptoms in a case of severe suicidal digoxin toxicity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: